MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders

psych_news
Written By Guest User
Guest User
Previous

Inside the Dispute Over a High-Profile Psychedelic Study
Next

Europe’s first psychedelic drug trial firm to open in London